Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Akorn Inc (AKRX)

Akorn Inc (AKRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Akorn Inc 1925 WEST FIELD COURT SUITE 300 LAKE FOREST IL 60045 USA

www.akorn.com P: 847-279-6100

Description:

Akorn, Inc. is a specialty generic pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals. They specialize in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. Akorn markets its products to retail pharmacies, ophthalmologists, optometrists, physicians, veterinarians, hospitals, clinics, wholesalers, distributors, group purchasing organizations, and government agencies. Their strategy is focused on continuing to strengthen our leadership position in the development and marketing of specialized generic and branded pharmaceuticals, over-the-counter (`OTC`) drug products and animal health products.

Key Statistics

Overview:

Market Capitalization, $K 11,984
Shares Outstanding, K 133,152
Annual Sales, $ 682,430 K
Annual Net Income, $ -226,770 K
Last Quarter Sales, $ 204,690 K
Last Quarter Net Income, $ -256,730 K
60-Month Beta 1.15
% of Insider Shareholders 3.90%
% of Institutional Shareholders 64.03%
Float, K 127,959
% Float 96.10%

Growth:

1-Year Return -97.80%
3-Year Return -99.73%
5-Year Return -99.81%
5-Year Revenue Growth 15.07%
5-Year Earnings Growth -130.36%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.02 on 10/31/19
Latest Earnings Date N/A
Earnings Per Share ttm 0.14
EPS Growth vs. Prev Qtr 409.09%
EPS Growth vs. Prev Year 342.86%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payable Date 07/01/91
Dividend Payout Ratio 0.00%

AKRX Ratios

Ratio
Price/Earnings ttm 0.64
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 8.53%
Return-on-Assets % 1.31%
Profit Margin % -33.23%
Debt/Equity -1.10
Price/Sales 0.02
Price/Cash Flow 0.19
Price/Book N/A
Book Value/Share -0.15
Interest Coverage -3.15
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar